BioSpace News Archive

DRADS Capital announced its investment in ROKIT Healthcare Inc., a South Korean biotechnology company developing innovative 4D bioprinting techniques and applications, in its Series C funding round of undisclosed amount.

Crown Laboratories, a leading skincare company committed to skin science for life, announced that Sarna Lotion, Crown’s steroid-free anti-itch moisturizer, has just been awarded the prestigious NEA Seal of Acceptance™.

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Grifols S.A., its collaborative partner in Europe , has launched TAVLESSE ® in Germany and the United Kingdom . It was approved by the European Commission in Janu

- Five coagulation researchers named this year’s recipients - Professor Heimburger Awards and ISTH Virtual Congress sponsorship showcase CSL Behring’s commitment to hematology research

Pascal Biosciences Inc. (TSXV:PAS)(OTC PINK:BIMUF) (“Pascal” or the “Company”) today announced the appointment of Dr. H. Michael Shepard to its Board of Directors.

Medela’s Healthcare business receives prestigious recognition for its ongoing efforts to support WOC Nurses across the country

Spacelabs Healthcare, a global designer and manufacturer of patient monitoring and diagnostic cardiology solutions, today announced that it has acquired an innovative cloud platform developed by BoxView, LLC (“Boxview”).

Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (“PAD”), today announced that the underwriters of its previously announced underwritten public offering have exercised,

In lieu of an in-person update to the media, Dr. Howard Njoo, Canada’s Deputy Chief Public Health Officer, issued the following statement on behalf of Dr. Theresa Tam, Canada’s Chief Public Health Officer.

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today provided an update on its effort to identify compounds to potentially address the COVID-19 pandemic. As previously announced, on April 13, 2020 , AIkido executed a